Modelling human liver disease: from steatotic liver disease to MASH-HCC

Christian Stoess,Ariel E. Feldstein

DOI: https://doi.org/10.1038/s41574-024-01054-z

2024-10-25

Nature Reviews Endocrinology

Abstract:Having more refined mouse models of metabolic dysfunction-associated steatotic liver disease (MASLD; also known as nonalcoholic fatty liver disease) will help to advance research into this disease. In their study, Jeong and colleagues use streptozotocin together with a high-fat diet for 6–60 weeks to investigate the progression from MASLD to hepatocellular carcinoma.

endocrinology & metabolism